NCT05665348 2026-03-09
TRIPLET
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
Clinical Trials
12 trialsNCT06904170 2026-02-03
ALICE
UNICANCER
Phase 2/3 Recruiting
NCT07309419 2025-12-30
Cocktail-001
Shanghai Zhongshan Hospital
Phase 2/3 Not yet recruiting
NCT07293468 2025-12-19
BIIRTH
Tuen Mun Hospital
Phase 2/3 Recruiting
NCT05171166 2025-12-18
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
Phase 2/3 Terminated
NCT05033522 2025-10-23
ALIVE
Mirror Biologics, Inc.
Phase 2/3 Suspended
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT06644937 2025-09-23
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
Zhujiang Hospital
Phase 2/3 Recruiting
NCT06109272 2025-08-15
LIVIGNO-2
AbbVie
Phase 2/3 Recruiting
NCT06999512 2025-05-31
HPB70+
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Not yet recruiting
NCT04521153 2025-05-11
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 2/3 Active not recruiting
NCT06911086 2025-04-04
SH-LPS System in Preoperative Planning for Liver Resection
Zhejiang Cancer Hospital
Phase 2/3 Not yet recruiting